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Background. Prior studies offer conflicting findings on whether Alzheimer's disease (AD) is associated with an increased
risk of hospitalization.
Methods. We investigated AD and hospitalization in the Washington Heights-Inwood Columbia Aging Project (WHICAP).
a community-based study of 2,334 elders in New York City. In 1996, an electronic medical records system was established that
allows an e-mail alert to be sent to the research team whenever WHICAP subjects are admitted to Columbia-Presbyterian
Medical Center (CPMC), the site of hospital care for the majority of subjects.
Results. Of the WHICAP cohort, 13.1% was admitted to CPMC in 21 months of follow-up; 17.5% ofAD patients and
11.9% of unaffected subjects were admitted (p < .01). Multivariate logistic regression models showed that more advanced AD
(Clinical Dementia Rating scale 3+) was a significant risk factor for hospitalization independently of age, gender, education,
comorbid medical conditions, and death in the follow-up period (OR 2.3; 95% CI: 1.1, 4.6); subjects with mild or moderate AD
did not show a significantly elevated risk. The prevalence of psychiatric symptoms did not differ between AD subjects who
were hospitalized in the reporting period and AD subjects who were not hospitalized. Infectious disease was a more common
discharge diagnosis for subjects with AD (p < .05).
Conclusions. In this community-based cohort, subjects with severe AD were more likely to be hospitalized than unaffected
subjects. The increased use of hospital care by these AD patients appears to be specific to AD but is not a result of psychiatric
morbidity or end-of-life care. Rather, a greater risk of medical complications that require hospital care. especially infections, ap-
pears to be characteristic of severe AD.
ALZHEIMER'S disease (AD) is a common disease oflate
./"\.. life, affecting 5%-10% of the population aged 65 and
older (1). However, the significance ofAD for use of health ser-
vices has only recently become a topic of research. Prior stud-
ies offer conflicting findings on whether AD is associated with
an increased risk of hospitalization relative to unaffected elders.
These studies have reported greater hospital utilization (2,3) but
also no differences or even lower use (4,5). A clearer under-
standing of the association between AD and hospitalization
would be valuable for determining the cost of AD care and also
for assessing whether people with AD are at risk for receiving
less aggressive medical care than other elders (6).
The Washington Heights-Inwood Columbia Aging Project
(WHICAP) offers important data on AD and risk of hospitaliza-
tion. A total of 2,334 older adults were enrolled in the study in
1992, with follow-up assessments in 1994-95 (n =1520) and
1996-97 (n = 1145). At each follow-up, subjects received neu-
ropsychological, neurologic, and functional assessments, allowing
diagnosis ofAD in accord with standardized criteria (7). In this
area of New York City, the majority of hospital care is provided by
a single hospital, Columbia-Presbyterian Medical Center
(CPMC). Beginning in 1996, an electronic medical records sys-
tem was established for WHICAP participants. In this system,
every hospital admission of a WHICAP subject is flagged, with
an electronic mail "alert" sent to the research team. Thus, ascer-
tainment of CPMC hospitalization in this cohort is complete for
the period corresponding to the second follow-up survey.
The WHICAP cohort, then, offers important advantages for ex-
amining AD and hospitalization.Actual hospital admission data (as
opposed to self- or proxy reports) are available,as well as actual di-
agnoses ofAD (as opposed to results from cognitive screening
tests alone). Moreover, the geography and limited medical care of
the region link the cohort, for the most part, to a single hospital.
METHODS
Sample
Subjects recruited into WHICAP came from two sources: a
stratified random sample drawn from Health Care Financing
Administration (HCFA) eligibility files (n = 2124), and targeted
recruitment of elders with cognitive impairment drawn from a
case reporting system of elders receiving services (n =210).
Sampling strata for this survey included age (65-74, 75-84, 85+),
gender, and race-ethnicity (Hispanic, non-Hispanic black, non-
Hispanic white). For the HCFA-based survey,systematic replicate
subsamples were drawn using random starts, such that each sub-
sample contained age and racial-ethnic groups of equal size. The
response rate for the entire sample at baseline was 70% (8-10).
All WHICAP subjects alive at the beginning of the hospital
reporting period (January, 1996) were included in this study (N
= 2003). These subjects represent 85.8% of the original cohort.
Measures
Alzheimer's disease status.-All WHICAP subjects completed
a full battery of neuropsychological tests. Subjects meeting neu-
ropsychological criteria for AD (7,11,12) were examined by a
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mented subjects were also examined by neurologists. Severity of
AD was staged according to the Oinical Dementia Rating (CDR)
scale (13). In this staging system, physicians rate patient function
along six dimensions and derive a composite score indicating
mild, moderate, severe, profound, or terminal disease. We di-
vided subjects with AD into two groups, those with mild-moder-
ate disease (CDR 1-2) and those with more severe disease (CDR
3+). For these analyses, we used the last diagnosis available. Of
the total WHICAP cohort, 1,978 (98.8%) were diagnosed.
Hospitalizationeventmonitoringsystem-The hospital admis-
sions period monitored extended from January 1, 1996, to
September 30, 1997, a period of21 months. The CPMC elec-
tronic reporting system documented subjects' admissions, length
of stay for each admission, and discharge diagnoses. The e-mail
alert program was created by the CPMC Department ofMedical
Informatics as part of an effort to use medical records more effec-
tively for clinical and epidemiological research. Once an alert was
received, subjects' hospital stays were monitored; research physi-
cians reviewed patients' charts and coded discharge diagnoses into
1 of 11 categories: surgery, metabolic/nutritional disorders,
trauma, pneumonia, other infections, cardiovascular disease, cere-
brovascular disease, malignancy,hip fracture, other,or unknown.
Number of hospitalizations was recorded for each subject,
along with a dichotomous variable indicating "no" or "any"
hospitalization in the reporting period. Length of stay was cal-
culated by summing the number of days spent in the hospital
across discrete admissions.
Reported hospitalizations: concurrent second follow-up sur-
vey.-During the period in which CPMC hospitalizations were
electronically monitored, the WHICAP sample also underwent
a concurrent, second follow-up survey assessment, in which in-
formation was collected from 1,145 respondents or their prox-
ies. At this assessment, subjects or proxies reported on hospital-
izations that occurred throughout the prior year, both at CPMC
and elsewhere. For subjects whose admission dates preceded
the interview date, we compared self- or proxy-reported CPMC
hospitalizations to CPMC admission records. We also exam-
ined reports of admissions to other hospitals in the region
(Harlem Hospital Center, Montefiore, St. Luke's-Roosevelt,
Mt. Sinai, and Bronx VA). Using these data, we examined the
proportion of hospitalizations that occurred at CPMC and
whether subjects with AD differed from unaffected subjects in
the likelihood of a CPMC hospitalization.
Assessment ofmedical comorbidities.-A subset ofWH-
ICAP subjects received a medical examination by research team
physicians as part of their follow-up. For these patients, physi-
cians conducted exams, inspected medications, and interviewed
patients and proxies about medical conditions. Physicians
recorded the presence or absence of 12 medical conditions (my-
ocardial infarct/ischemic heart disease, congestive heart failure,
peripheral vascular disease, cerebrovascular disease, dementia,
chronic obstructive pulmonary disease, peptic ulcer, liver dis-
ease, diabetes, renal disease, and systemic malignancy).
A modified comorbidity index was calculated following
Charlson's recommendations (14). The Charlson index weights
comorbid conditions by the strength of their association with
mortality; a weighted sum is then calculated. Following this ap-
proach, chronic liver disease, chronic obstructive pulmonary
disease, gastrointestinal disease, myocardial infarction, dia-
betes, peripheral vascular disease, stroke, arthritis, and hyper-
tension were all assigned a weight of 1; chronic renal disease
and systemic malignancy were assigned a weight of 2. Subjects
were then categorized according to the following scores: 0 (no
comorbid condition), 1 (one comorbid condition), 2 (two co-
morbid conditions or one of the more severe conditions), 3+
(three or more conditions, or at least one severe condition with
another condition). For this measure we used subjects' last med-
ical examination, which was available for 1,034 subjects.
Information on psychiatric comorbidity was also collected
for subjects meeting criteria for AD. For this assessment, sub-
jects' proxies completed the Columbia University Scale for
Psychopathology in Alzheimer's Disease (CUSPAD), which
records the presence of psychiatric symptoms common in
AD patients (15).
Analyses
Totalhospital use and CPMC admissions.-WHICAP sub-
jects and proxies were asked to report all hospital use and site(s)
of hospitalization. We calculated the proportion of total hospital
use accounted for by CPMC admissions and whether subjects
with AD differed from unaffected subjects in the likelihood of a
CPMC admission.
Comparison ofmedical recordadmissionsto interview-reported
admissions.-Subject and proxy reports of CPMC hospitalization
were cross-classified with electronic hospital admission data. The
sensitivity and specificity of reported admissions were calculated
using the electronicmedical record as the criterion.
Rates ofCPMC admission.-The proportion of subjects with
a CPMC medical record admission over the reporting period
was calculated for unaffected subjects, subjects with mild or
moderate AD, and subjects with severe AD. In addition, other
predictors of hospital admission were examined, including so-
ciodemographic status (gender, age, education, race-ethnicity),
number of comorbid medical conditions (modified Charlson
index), and whether subjects died during the reporting period.
The last is an important predictor because a large proportion of
hospital care involves end-of-life care (16). Multivariate logistic
models were developed to examine predictors of hospitalization
and to determine ifAD diagnosis was a significant, independent
predictor of hospitalization, controlling for these other factors.
Features of AD potentially associated with hospitaliza-
tion.-Because psychiatric morbidity is a feature ofAD and may
also bea cause of hospitalization, AD subjects who were hospi-
talized in the reporting period were compared to those who were
not to determine if levels of psychiatric symptoms differed.
Discharge diagnoses of AD and non-AD patients were also com-
pared to determine if subjects with AD were hospitalized for dif-
ferent conditions than elders without AD.
REsULTS
Totalhospital use and CPMC admissions.-In the WHICAP










AD AND HOSPITALIZATION M269
CPMC, as documented by the electronic reporting system, over
the 21-month reporting period. Number of admissions among
these subjects ranged from 1 to 11, but 61.6% had a single ad-
mission over this period.
Total length of stay, summated, when necessary, over re-
peated admissions, ranged from 1 to 158 days. Median total
length of stay was 8 days.
Information obtained from subject interviews suggests that
the CPMC electronic records system captured the majority of
hospitalizations in the cohort. Of the 1,145 subjects completing
an in-person interview in 1996-97, 20.1% reported at least one
hospitalization and 63% of these were reported as CPMC admis-
sions. AD and non-AD WHICAP subjects (or proxies) were
equally likely to report CPMC as the site of hospitalization (71%
and 61% of reported hospitalizations, respectively,p = .20).
Comparison of medical record admissions to interview-
reported admissions.-Comparing interview-reported CPMC
admissions to admissions documented in the electronic records
system showed that the sensitivity of interview reports was
69.8% and specificity was 92.5%.
Finally, the subjects who died in the reporting period (2.8%)
were also more likely to have had a CPMC admission reported
in the electronic records system. Of the subjects who died,
21.4% had been admitted to CPMC in the 21 months of the re-
porting period, compared to 12.8% of those who did not die in
this period (p =.06). Subjects with AD were also more likely to
die in this period than subjects who did not meet criteria for AD
(5.4% vs 2.1%,p < .001).
Multivariate analyses of hospitalization.-Multivariate
logistic regression models showed that more advanced AD was a
significant risk factor for hospitalization independent of sociode-
mographic factors, comorbid medical status, and death in the re-
porting period. This finding is shown in Table 2, which presents
two models, one without comorbid medical status as a predictor
(n =1978) and one including this predictor (n =993), because of
the different sample sizes used in constructing the two models.
In both models, severe AD was an independent predictor of
hospitalization (Modell: OR 2.3; 95% CI: 1.3,4.0; Model 2: OR
2.3,95% CI: 1.1,4.6). In neither model was mild-moderate AD
Table1.Features of WHICAPCohortby Hospitalization Status
Predictor(n) HospitalAdmission(%)





















































Rates ofCPMC admission.-Characteristics of subjects who
had a medical record-documented CPMC admission over the
reporting period are shown in Table 1.
Men and women were equally likely to have a hospitaliza-
tion (13.5% of males in the cohort were hospitalized, compared
to 12.9% offemales,p = .74). Risk of hospitalization increased
with age, ranging from 11.7% among those younger than 70 to
17.9% among those 85 and older; however, this relationship did
not achieve statistical significance (p = .11). Risk of hospital-
ization also did not differ among ethnic-racial groups: 12.1% of
the whites, 11.4% of the African Americans, and 14.7% of the
Hispanics had a CPMC admission during this period. By con-
trast, level of education was a significant predictor of hospital-
ization. Of the WHICAP subjects who had completed high
school, 10.4% had a CPMC hospitalization in the reporting pe-
riod, compared to 15.8% and 16.0% among subjects whose ed-
ucation did not go beyond elementary school (p < .03).
Of the 2,003 WHICAP subjects alive at the beginning of the
electronic medical record monitoring period, 99 (4.9%) were re-
siding in nursing homes. CPMC hospitalization rates, as indicated
by the electronic medical record, were higher among these sub-
jects (17.2%) than among non-nursing home subjects (12.9%),
but this difference did not achieve statisticalsignificance (p = .22).
Comorbid conditions were strongly associated with risk of
hospitalization: 8.9% of subjects with no comorbid conditions
at their last assessment were hospitalized, compared to 18.1%
among subjects with a Charlson score of 1, 19.7% among sub-
jects with a score of 2, and 25.1% among subjects with scores
of 3 or more on the index (p < .0001).
AD was also associated with a significant increase in the risk
of hospitalization over the reporting period. Of subjects with
AD, 17.5% were hospitalized, compared to 11.9% of subjects
without AD (p < .01). This risk increased with severity of AD,
as indexed by CDR scale score. While 11.9% of subjects with-
out AD had a CPMC admission, the risk was 15.9% for sub-
jects with dementia of mild or moderate severity (odds ratio
[OR] 1.4,95% confidence interval [CI]: 1.0, 1.9) and 26.4% for











significantly associated withhospitalization. Higherscoreson the
comobidity index werealso significantly associatedwith risk of
hospitalization, and loweducationremaineda significant predic-
torevenwithinclusion of comorbid medicalstatus in themodel.
Number ofhospitalizations and hospital length ofstay.-For
people with documented admissions to CPMC, we examined
number of hospitalizations and total length of stay by AD status
and scores on the comorbidity index. While AD severity pre-
dictedrisk of hospitalization, severity was not significantlyas-
sociatedwith number of hospitalizationsor lengthof stay.Both
AD and non-AD patients with CPMC admissions averaged
about two admissions.Likewise,length of stay across these ad-
missions did not significantly differ. Subjects withoutAD spent
a mean of 17.6 days in the hospital, compared to 14.4 days
among patients with mild-moderateAD, and 14.9days among
patientswith severeAD.
By contrast, comorbidmedical statuswas stronglyassociated
withnumberof admissions andlengthof stayamongsubjects hos-
pitalizedin the reporting period. For thesesubjects, thenumberof
admissions was 1.3amongsubjects withno comorbidities, 1.7for
subjects with scoresof 1,2.0for subjects withscores of 2, and 2.6
for subjects with scores of 3 or more on the modified Charlson
index(p < .01).Similarly, totallengthof staywas 10.3, 14.3,20.8,
and25.2days,respectively, according to Charlson score (p< .03).
Table2. Predictors of Hospitalization:
Multivariate LogisticRegression
Modell (n = 1978) Model 2 (n = 1034)
Predictor OR(95%CI) OR (95% CI)
Gender
Male (reference) 1.0 1.0
Female 0.9 (0.7,1.2) 0.9 (0.6,1.4)
Age (yr)
gO (reference) 1.0 1.0
71-74 1.0 (0.7,1.5) 0.9 (0.6,1.6)
75-78 Ll (0.7, 1.6) 0.9 (0.5, 1.6)
79-84 Ll (0.7,1.7) 0.9 (0.5,1.7)
>85 1.4 (1.0,2.5) Ll (0.6,2.0)
Education (yr)
0-3 1.6 (1.0,2.5) 2.0 (1.0,4.1)
4-6 1.5 (0.8,2.1) 2.4 (Ll,4.8)
7-9 1.3 (0.6,1.6) 2.0 (1.0,4.0)
10-12 1.0 (0.7,1.6) 1.2 (0.6,2.3)
13+ (reference) 1.0 1.0
Death
Alive (reference) 1.0 1.0
Dead in reporting period 1.7 (0.9,3.4) 1.6 (0.7,3.6)
Alzheimer's Disease Diagnosis
Normal (reference) 1.0 1.0
Mild-moderate AD Ll (0.7,1.6) 1.2 (0.7,1.8)






*Note: OR = odds ratio; CI = confidence interval.
Features ofAD relevantfor hospitalization.-Discharge di-
agnoses for AD and non-AD groups were similar except in the
case of infectious disease. Of subjects with AD who were hos-
pitalized, 40.8% had pneumonia or other infectious disease as
their coded discharge diagnosis, compared to 27.2% among
subjectsnot meeting criteriafor AD (p < .05).
Psychiatric morbidity,a common featureof AD, was also ex-
aminedas a cause of the increasedlikelihoodof hospital admis-
sionsamongsubjectswithAD. However, hospitalized elderswith
AD did not showa significantly higherprevalence of psychiatric
symptoms or behavioralagitation thanelderswithAD who were
not hospitalized (25.5%vs 20.0%,respectively, p = .29).
Finally, we examined hospital use among AD and non-AD
subjectswho died in the follow-upperiod.Among subjectswho
died in the reportingperiod, subjectswithAD were more likely
to have been hospitalized than subjects without AD. Seven out
of 22 (31.8%)of AD subjectswho died were hospitalizedin the
reporting period, compared to 5 out of 34 (14.7%) of non-AD
subjectswho died (p < .01). The time between first hospitaliza-
tion and death ranged from 13 to 368 days and did not signifi-
cantly differbetweenAD and non-AD subjects.
DISCUSSION
This community-based study shows that elders meeting cri-
teria for AD face an increased risk of hospitalizationrelative to
cognitively normal elders; 17.5% of subjects with AD were
hospitalizedat Columbia-PresbyterianMedical Center over 21
months, compared to only 11.9% of subjects without AD.
These rates do not account for all hospitalizations, but only
those occurringat CPMC. Data collectedduring the concurrent
surveysuggest that these hospitalizations account for about two
thirds of all subjects who were hospitalized (71% of AD sub-
jects, 61% of non-AD subjects). We can therefore impute total
hospital use.With such an imputation, the annual risk of hospi-
talization was 11.1% among non-AD patients, 14.1% among
all AD patients, and 21.2% for subjects with severeAD, as de-
finedby a CDR score of 3+.
The elevatedrisk of hospitalizationassociatedwith more ad-
vanced dementia was independent of other factors associated
with hospitalization, such as age, education, comorbid condi-
tions, and subsequent mortality. The increased risk, therefore,
appears to be specific to advancedAD, although not explained
by the psychiatric morbidity typical of the disease or the in-
creased risk of death associatedwithAD. AD patients admitted
to CPMC and AD patients without an admission were equally
likely to havepsychiatric symptoms,and severeAD was signif-
icantly associated with hospitalization even when controlling
for death in the follow-upperiod.
AD patients who were hospitalized differed from non-AD
patientshospitalizedin the same period (and at the same hospi-
tal) in only one discharge diagnosis, infectious disease (40.8%
vs 27.2%), as coded by physicians who inspected dischargedi-
agnoses.Therefore, we conclude that at least part of the excess
risk of hospitalizationassociatedwithAD is likely due to an in-
creased risk of infection-in particular, pneumonia, requiring
hospital treatment. It is possible, however, that infectionscoded
on the dischargediagnosismay also havehad a nosocomialori-
gin. We are currentlyinvestigating this issue.
An important feature of this community-based study is its
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ports, in a geographic area where a single hospital is the major
sourceof hospitalcare.The proportionof AD and non-ADsub-
jects (or proxies) in Washington Heights-Inwoodwho reported
CPMC as the site of hospital admission in a concurrent inter-
view did not significantly differ.Thus, it appears that the two
groups were equally likely to use CPMC for hospital care.
Another important aspect of the study is its use of actual diag-
nosesof AD based on a full batteryof neuropsychological tests
and neurologic examination. Prior population-based studies
have relied, for the most part, on screening tests to identify
olderadultswith cognitive impairment(2,3).Other studies have
addressedthe risk of hospitalization amongAD patientsbut re-
lied on patients drawn from AD registries or research centers
and did not include information on rates of hospitalization
amongelders withoutAD (5).
The most relevant study for comparisonis the Monongahela
ValleyIndependent Elders Survey,which is population-based
and which included hospitalization as an outcome (3).
However, the MonongahelaValleystudy did not diagnoseAD
but rather defined "cognitive impairment" empirically.
Cognitive impairmentwas definedas a scorebelowthe 5th per-
centile of the sample distribution for the Mini-Mental State
Examinationor for two other cognitivetests, includingone test
of memory. By this standard,Ganguli and colleagues(3) found
that 19.1% of cognitively impaired elders were hospitalized
over a 6-month period, compared to 10.2% of unimpaired el-
ders. These rates were based upon subject or proxy reports of
hospitaluse, and the greaterrisk for hospitalization amongcog-
nitivelyimpaired elders was no longer significantin multivari-
ate models. In the WHICAP cohort, by contrast, advancedAD
remained a significant risk factor for hospitalization in multi-
variatemodels that included sociodemographic factors,comor-
bid conditions, and deathduringthe follow-up period.
Despite the increased risk of hospitalizationassociated with
advanced AD in the WHICAP cohort, we did not find an in-
creasedlength of stay or increasednumber of admissionswhen
we limited analyses to patients who had been admitted to the
hospital. This contrasts with findings reported by Weiler and
colleagues (2), who reported that "moderate/severe" cognitive
impairment was associatedwithan increasedrisk of longerhos-
pital staysin the late 1980s. Perhapsbecauseof changingtrends
in hospital care, severely affected AD patients in WHICAP
were more likely to be hospitalizedbut not more likely to have
longerlengthof staysonce admitted.
Our results suggest that severeAD is a significant,indepen-
dent risk factor for hospitalization.For severeAD, then, we do
not findevidencethat aggressive care, at least as it is indexedby
hospital admissions, is limited. This finding supports research re-
portedby FriedandGillick(6).Theyfoundthatfamily caregivers
werelikely to limit aggressive care for elders with terminaldis-
ease and for elders in institutional settings, but found no such
limitation forelderswithdementia living in community settings.
We conclude that the "malignancy" of AD (17) includes not
simply greater risk of death, but also greater risk of medical
complications, especially infections, that requirehospitalcare.
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